Gene · 862
Papers4,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,881 to 1,900 of 4,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Unusual Karyotype in Acute Myelomonocitic Leukemia: A Case Report. | Anticancer Res | 2019 | 31366525 | PubTator, text mining | PubMed |
| Identification of a novel long non-coding RNA within RUNX1 intron 5. | Hum Genomics | 2019 | 31366376 | PubTator, text mining | PubMed |
| High aldehyde dehydrogenase activity at diagnosis predicts relapse in patients with t(8;21) acute myeloid leukemia. | Cancer Med | 2019 | 31364309 | PubTator, text mining | PubMed |
| Non-coding RNAs in cancers with chromosomal rearrangements: the signatures, causes, functions and implications. | J Mol Cell Biol | 2019 | 31361891 | PubTator, text mining | PubMed |
| Ultrastructural, cytogenetic, and molecular findings in mast cell leukemia: Case report. | Clin Case Rep | 2019 | 31360496 | PubTator, text mining | PubMed |
| Prognostic significance of MYC oncoprotein expression on survival outcome in patients with acute myeloid leukemia with myelodysplasia related changes (AML-MRC). | Leuk Res | 2019 | 31357093 | PubTator, text mining | PubMed |
| Genomic sequencing identifies WNK2 as a driver in hepatocellular carcinoma and a risk factor for early recurrence. | J Hepatol | 2019 | 31349001 | PubTator, text mining | PubMed |
| Genetic alteration patterns and clinical outcomes of elderly and secondary acute myeloid leukemia. | Hematol Oncol | 2019 | 31348835 | PubTator, text mining | PubMed |
| New perspectives on treatment strategies for patient with acute myeloid leukemia and complex karyotype abnormalities after percutaneous coronary intervention: A case report. | Medicine (Baltimore) | 2019 | 31348297 | PubTator, text mining | PubMed |
| [Clinical, molecular and cytogenetic characteristics of newly diagnosed adult acute myeloid patients with TP53 gene mutation]. | Zhonghua Xue Ye Xue Za Zhi | 2019 | 31340630 | PubTator, text mining | PubMed |
| The molecular genetic make-up of male breast cancer. | Endocr Relat Cancer | 2019 | 31340200 | PubTator, text mining | PubMed |
| Signaling Pathways in Leukemic Stem Cells. | Adv Exp Med Biol | 2019 | 31338813 | PubTator, text mining | PubMed |
| Small Nucleolar RNAs: Insight Into Their Function in Cancer. | Front Oncol | 2019 | 31338327 | PubTator, text mining | PubMed |
| The Regulatory Roles of Long Noncoding RNAs in Acute Myeloid Leukemia. | Front Oncol | 2019 | 31338324 | PubTator, text mining | PubMed |
| Data-driven characterization of molecular phenotypes across heterogeneous sample collections. | Nucleic Acids Res | 2019 | 31329928 | PubTator, text mining | PubMed |
| CellSIUS provides sensitive and specific detection of rare cell populations from complex single-cell RNA-seq data. | Genome Biol | 2019 | 31315641 | PubTator, text mining | PubMed |
| Oncogenic KIT mutations induce STAT3-dependent autophagy to support cell proliferation in acute myeloid leukemia. | Oncogenesis | 2019 | 31311917 | PubTator, text mining | PubMed |
| Comparison of effects of midostaurin, crenolanib, quizartinib, gilteritinib, sorafenib and BLU-285 on oncogenic mutants of KIT, CBL and FLT3 in haematological malignancies. | Br J Haematol | 2019 | 31309543 | PubTator, text mining | PubMed |
| Integrative analysis of the lncRNA-associated ceRNA network reveals lncRNAs as potential prognostic biomarkers in human muscle-invasive bladder cancer. | Cancer Manag Res | 2019 | 31308745 | PubTator, text mining | PubMed |
Clinical efficacy of decitabine in combination with standard-dose cytarabine, aclarubicin hydrochloride, and granulocyte colony-stimulating factor in the treatment of young patients with newly diagnosed acute myeloid leukemia. | Onco Targets Ther | 2019 | 31303761 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/862/papers?page=95